Source: Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Kehagia, L. Andri, E. Sekara, C. Syrigos, M. Linardakis, E. Zervas, C. Marossis, N. Papageorgiou (Athens, Greece). Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment. Eur Respir J 2001; 16: Suppl. 31, 2227

Member's Comments

No comment yet.

Related content which might interest you: IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 234s Year: 2006 The role of ECP, IL-4 and IL-5 in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Values of systemic ECP, IL-4 and IL-5 in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene) Source: Eur Respir J 2001; 18: Suppl. 33, 371s Year: 2001 IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005 Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES) Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Montelukast reduces Th2 type cytokines in induced sputum in mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019